Global Healthcare Contract Research Organization Market

Healthcare Contract Research Organization Comprehensive Study by Type (Early Phase development, Clinical research, Laboratory regulatory Consulting), Therapeutic Areas (Oncology, CNS Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunological Disorders, Respiratory Disorders, Diabetes, Other), End-User (Pharmaceutical and Biopharmaceutical Companies, Medical Device Companies, Academic Institutes), Service Type (Early Phase Development Services {Discovery Studies, Chemistry, Manufacturing & Control, Preclinical Services}, Pharmacokinetics /Pharmacodynamics, Toxicology Testing, Clinic Research Services {Phase I, Phase II, Phase III, Phase IV}, Laboratory Services {Bioanalytical Testing, Analytical Testing}, Physical Characterization, Testing {Stability Testing, Batch Release Testing, Raw Material Testing, Other Analytical Testing}, Consulting Services) Players and Region - Global Market Outlook to 2030

Healthcare Contract Research Organization Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 20.3%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Healthcare Contract Research Organization
A Contract Research Organization is a corporation appointed by a corporation within the medical field to manage the company's clinical trials and perform other tasks to support bring a drug or device to the market. The organization is usually contract with companies within the pharmaceutical, biotechnology, or medical device industries, but their clients also include governmental institutions, foundations, and universities. These organizations contract with CROs to accumulate the precise expertise needed to hold out trials safely and efficiently without hiring permanent staff.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
CAGR20.3%


Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Healthcare Contract Research Organization market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

IQVIA Holdings, Inc. (United States), Laboratory Corporation of America Holdings (United States), Pharmaceutical Product Development, Inc. (United States), Parexel International Corporation (United States), Charles River Laboratories International, Inc. (United States), ICON PLC (Ireland), Medidata Solutions, Inc. (United States), Syneos Health, Inc. (United States), Pharmaron Beijing Co., Ltd. (China) and GVK Biosciences Private Limited (India) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are SGS SA (Switzerland), EPS International Co., Ltd (Japan) and Genscript Biotech (United States).

Segmentation Overview
AMA Research has segmented the market of Global Healthcare Contract Research Organization market by Type (Early Phase development, Clinical research and Laboratory regulatory Consulting) and Region.



On the basis of geography, the market of Healthcare Contract Research Organization has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Therapeutic Areas, the sub-segment i.e. Oncology will boost the Healthcare Contract Research Organization market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End-User, the sub-segment i.e. Pharmaceutical and Biopharmaceutical Companies will boost the Healthcare Contract Research Organization market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Service Type, the sub-segment i.e. Early Phase Development Services {Discovery Studies, Chemistry, Manufacturing & Control, Preclinical Services} will boost the Healthcare Contract Research Organization market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Growing Consolidation in the CROs Industry

Market Growth Drivers:
Increasing R&D Investment in Clinical & Non-Clinical Research Activities and Increasing Demand Of Outsourcing Analytical Testing And Clinical Trial Services

Challenges:
Intellectual property right issues and Stringent regulatory policies

Restraints:
Regulatory Pressure on CRO Service Providers

Opportunities:
Untapped Emerging Economies, Growing Biosimilars and Biologics Market and Rising Demand for Specialized Testing Services

Market Leaders and their expansionary development strategies
In October 2023,Curavit Clinical Research, a virtual contract research organization (VCRO) that specializes in decentralized clinical trials (DCTs) for digital therapeutics (DTx), launches new Health Economics and Outcomes Research (HEOR) Practice. Curavit will incorporate HEOR services in clinical trials to capture evidence of the health economics value of novel pharmaceutical products, especially digital therapeutics which are striving to accelerate market momentum.
In March 2020, Medidata signed an agreement with Medpace Inc. for integrating Medidata Rave Imaging with Medpace's imaging systems and workflow. The integration is expected to create a seamless platform for capturing, managing, analyzing, and storing images and imaging data for clinical trials.


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Healthcare CRO Services Providers, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End Use Industry

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Early Phase development
  • Clinical research
  • Laboratory regulatory Consulting
By Therapeutic Areas
  • Oncology
  • CNS Disorder
  • Cardiovascular Disease
  • Metabolic Disease
  • Infectious Disease
  • Immunological Disorders
  • Respiratory Disorders
  • Diabetes
  • Other

By End-User
  • Pharmaceutical and Biopharmaceutical Companies
  • Medical Device Companies
  • Academic Institutes

By Service Type
  • Early Phase Development Services {Discovery Studies, Chemistry, Manufacturing & Control, Preclinical Services}
  • Pharmacokinetics /Pharmacodynamics
  • Toxicology Testing
  • Clinic Research Services {Phase I, Phase II, Phase III, Phase IV}
  • Laboratory Services {Bioanalytical Testing, Analytical Testing}
  • Physical Characterization
  • Testing {Stability Testing, Batch Release Testing, Raw Material Testing, Other Analytical Testing}
  • Consulting Services

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing R&D Investment in Clinical & Non-Clinical Research Activities
      • 3.2.2. Increasing Demand Of Outsourcing Analytical Testing And Clinical Trial Services
    • 3.3. Market Challenges
      • 3.3.1. Intellectual property right issues
      • 3.3.2. Stringent regulatory policies
    • 3.4. Market Trends
      • 3.4.1. Growing Consolidation in the CROs Industry
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Healthcare Contract Research Organization, by Type, Therapeutic Areas, End-User, Service Type and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Healthcare Contract Research Organization (Value)
      • 5.2.1. Global Healthcare Contract Research Organization by: Type (Value)
        • 5.2.1.1. Early Phase development
        • 5.2.1.2. Clinical research
        • 5.2.1.3. Laboratory regulatory Consulting
      • 5.2.2. Global Healthcare Contract Research Organization by: Therapeutic Areas (Value)
        • 5.2.2.1. Oncology
        • 5.2.2.2. CNS Disorder
        • 5.2.2.3. Cardiovascular Disease
        • 5.2.2.4. Metabolic Disease
        • 5.2.2.5. Infectious Disease
        • 5.2.2.6. Immunological Disorders
        • 5.2.2.7. Respiratory Disorders
        • 5.2.2.8. Diabetes
        • 5.2.2.9. Other
      • 5.2.3. Global Healthcare Contract Research Organization by: End-User (Value)
        • 5.2.3.1. Pharmaceutical and Biopharmaceutical Companies
        • 5.2.3.2. Medical Device Companies
        • 5.2.3.3. Academic Institutes
      • 5.2.4. Global Healthcare Contract Research Organization by: Service Type (Value)
        • 5.2.4.1. Early Phase Development Services {Discovery Studies, Chemistry, Manufacturing & Control, Preclinical Services}
        • 5.2.4.2. Pharmacokinetics /Pharmacodynamics
        • 5.2.4.3. Toxicology Testing
        • 5.2.4.4. Clinic Research Services {Phase I, Phase II, Phase III, Phase IV}
        • 5.2.4.5. Laboratory Services {Bioanalytical Testing, Analytical Testing}
        • 5.2.4.6. Physical Characterization
        • 5.2.4.7. Testing {Stability Testing, Batch Release Testing, Raw Material Testing, Other Analytical Testing}
        • 5.2.4.8. Consulting Services
      • 5.2.5. Global Healthcare Contract Research Organization Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Healthcare Contract Research Organization: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. IQVIA Holdings, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Laboratory Corporation of America Holdings (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Pharmaceutical Product Development, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Parexel International Corporation (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Charles River Laboratories International, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. ICON PLC (Ireland)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Medidata Solutions, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Syneos Health, Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Pharmaron Beijing Co., Ltd. (China)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. GVK Biosciences Private Limited (India)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Healthcare Contract Research Organization Sale, by Type, Therapeutic Areas, End-User, Service Type and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Healthcare Contract Research Organization (Value)
      • 7.2.1. Global Healthcare Contract Research Organization by: Type (Value)
        • 7.2.1.1. Early Phase development
        • 7.2.1.2. Clinical research
        • 7.2.1.3. Laboratory regulatory Consulting
      • 7.2.2. Global Healthcare Contract Research Organization by: Therapeutic Areas (Value)
        • 7.2.2.1. Oncology
        • 7.2.2.2. CNS Disorder
        • 7.2.2.3. Cardiovascular Disease
        • 7.2.2.4. Metabolic Disease
        • 7.2.2.5. Infectious Disease
        • 7.2.2.6. Immunological Disorders
        • 7.2.2.7. Respiratory Disorders
        • 7.2.2.8. Diabetes
        • 7.2.2.9. Other
      • 7.2.3. Global Healthcare Contract Research Organization by: End-User (Value)
        • 7.2.3.1. Pharmaceutical and Biopharmaceutical Companies
        • 7.2.3.2. Medical Device Companies
        • 7.2.3.3. Academic Institutes
      • 7.2.4. Global Healthcare Contract Research Organization by: Service Type (Value)
        • 7.2.4.1. Early Phase Development Services {Discovery Studies, Chemistry, Manufacturing & Control, Preclinical Services}
        • 7.2.4.2. Pharmacokinetics /Pharmacodynamics
        • 7.2.4.3. Toxicology Testing
        • 7.2.4.4. Clinic Research Services {Phase I, Phase II, Phase III, Phase IV}
        • 7.2.4.5. Laboratory Services {Bioanalytical Testing, Analytical Testing}
        • 7.2.4.6. Physical Characterization
        • 7.2.4.7. Testing {Stability Testing, Batch Release Testing, Raw Material Testing, Other Analytical Testing}
        • 7.2.4.8. Consulting Services
      • 7.2.5. Global Healthcare Contract Research Organization Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Healthcare Contract Research Organization: by Type(USD Million)
  • Table 2. Healthcare Contract Research Organization Early Phase development , by Region USD Million (2018-2023)
  • Table 3. Healthcare Contract Research Organization Clinical research , by Region USD Million (2018-2023)
  • Table 4. Healthcare Contract Research Organization Laboratory regulatory Consulting , by Region USD Million (2018-2023)
  • Table 5. Healthcare Contract Research Organization: by Therapeutic Areas(USD Million)
  • Table 6. Healthcare Contract Research Organization Oncology , by Region USD Million (2018-2023)
  • Table 7. Healthcare Contract Research Organization CNS Disorder , by Region USD Million (2018-2023)
  • Table 8. Healthcare Contract Research Organization Cardiovascular Disease , by Region USD Million (2018-2023)
  • Table 9. Healthcare Contract Research Organization Metabolic Disease , by Region USD Million (2018-2023)
  • Table 10. Healthcare Contract Research Organization Infectious Disease , by Region USD Million (2018-2023)
  • Table 11. Healthcare Contract Research Organization Immunological Disorders , by Region USD Million (2018-2023)
  • Table 12. Healthcare Contract Research Organization Respiratory Disorders , by Region USD Million (2018-2023)
  • Table 13. Healthcare Contract Research Organization Diabetes , by Region USD Million (2018-2023)
  • Table 14. Healthcare Contract Research Organization Other , by Region USD Million (2018-2023)
  • Table 15. Healthcare Contract Research Organization: by End-User(USD Million)
  • Table 16. Healthcare Contract Research Organization Pharmaceutical and Biopharmaceutical Companies , by Region USD Million (2018-2023)
  • Table 17. Healthcare Contract Research Organization Medical Device Companies , by Region USD Million (2018-2023)
  • Table 18. Healthcare Contract Research Organization Academic Institutes , by Region USD Million (2018-2023)
  • Table 19. Healthcare Contract Research Organization: by Service Type(USD Million)
  • Table 20. Healthcare Contract Research Organization Early Phase Development Services {Discovery Studies, Chemistry, Manufacturing & Control, Preclinical Services} , by Region USD Million (2018-2023)
  • Table 21. Healthcare Contract Research Organization Pharmacokinetics /Pharmacodynamics , by Region USD Million (2018-2023)
  • Table 22. Healthcare Contract Research Organization Toxicology Testing , by Region USD Million (2018-2023)
  • Table 23. Healthcare Contract Research Organization Clinic Research Services {Phase I, Phase II, Phase III, Phase IV} , by Region USD Million (2018-2023)
  • Table 24. Healthcare Contract Research Organization Laboratory Services {Bioanalytical Testing, Analytical Testing} , by Region USD Million (2018-2023)
  • Table 25. Healthcare Contract Research Organization Physical Characterization , by Region USD Million (2018-2023)
  • Table 26. Healthcare Contract Research Organization Testing {Stability Testing, Batch Release Testing, Raw Material Testing, Other Analytical Testing} , by Region USD Million (2018-2023)
  • Table 27. Healthcare Contract Research Organization Consulting Services , by Region USD Million (2018-2023)
  • Table 28. South America Healthcare Contract Research Organization, by Country USD Million (2018-2023)
  • Table 29. South America Healthcare Contract Research Organization, by Type USD Million (2018-2023)
  • Table 30. South America Healthcare Contract Research Organization, by Therapeutic Areas USD Million (2018-2023)
  • Table 31. South America Healthcare Contract Research Organization, by End-User USD Million (2018-2023)
  • Table 32. South America Healthcare Contract Research Organization, by Service Type USD Million (2018-2023)
  • Table 33. Brazil Healthcare Contract Research Organization, by Type USD Million (2018-2023)
  • Table 34. Brazil Healthcare Contract Research Organization, by Therapeutic Areas USD Million (2018-2023)
  • Table 35. Brazil Healthcare Contract Research Organization, by End-User USD Million (2018-2023)
  • Table 36. Brazil Healthcare Contract Research Organization, by Service Type USD Million (2018-2023)
  • Table 37. Argentina Healthcare Contract Research Organization, by Type USD Million (2018-2023)
  • Table 38. Argentina Healthcare Contract Research Organization, by Therapeutic Areas USD Million (2018-2023)
  • Table 39. Argentina Healthcare Contract Research Organization, by End-User USD Million (2018-2023)
  • Table 40. Argentina Healthcare Contract Research Organization, by Service Type USD Million (2018-2023)
  • Table 41. Rest of South America Healthcare Contract Research Organization, by Type USD Million (2018-2023)
  • Table 42. Rest of South America Healthcare Contract Research Organization, by Therapeutic Areas USD Million (2018-2023)
  • Table 43. Rest of South America Healthcare Contract Research Organization, by End-User USD Million (2018-2023)
  • Table 44. Rest of South America Healthcare Contract Research Organization, by Service Type USD Million (2018-2023)
  • Table 45. Asia Pacific Healthcare Contract Research Organization, by Country USD Million (2018-2023)
  • Table 46. Asia Pacific Healthcare Contract Research Organization, by Type USD Million (2018-2023)
  • Table 47. Asia Pacific Healthcare Contract Research Organization, by Therapeutic Areas USD Million (2018-2023)
  • Table 48. Asia Pacific Healthcare Contract Research Organization, by End-User USD Million (2018-2023)
  • Table 49. Asia Pacific Healthcare Contract Research Organization, by Service Type USD Million (2018-2023)
  • Table 50. China Healthcare Contract Research Organization, by Type USD Million (2018-2023)
  • Table 51. China Healthcare Contract Research Organization, by Therapeutic Areas USD Million (2018-2023)
  • Table 52. China Healthcare Contract Research Organization, by End-User USD Million (2018-2023)
  • Table 53. China Healthcare Contract Research Organization, by Service Type USD Million (2018-2023)
  • Table 54. Japan Healthcare Contract Research Organization, by Type USD Million (2018-2023)
  • Table 55. Japan Healthcare Contract Research Organization, by Therapeutic Areas USD Million (2018-2023)
  • Table 56. Japan Healthcare Contract Research Organization, by End-User USD Million (2018-2023)
  • Table 57. Japan Healthcare Contract Research Organization, by Service Type USD Million (2018-2023)
  • Table 58. India Healthcare Contract Research Organization, by Type USD Million (2018-2023)
  • Table 59. India Healthcare Contract Research Organization, by Therapeutic Areas USD Million (2018-2023)
  • Table 60. India Healthcare Contract Research Organization, by End-User USD Million (2018-2023)
  • Table 61. India Healthcare Contract Research Organization, by Service Type USD Million (2018-2023)
  • Table 62. South Korea Healthcare Contract Research Organization, by Type USD Million (2018-2023)
  • Table 63. South Korea Healthcare Contract Research Organization, by Therapeutic Areas USD Million (2018-2023)
  • Table 64. South Korea Healthcare Contract Research Organization, by End-User USD Million (2018-2023)
  • Table 65. South Korea Healthcare Contract Research Organization, by Service Type USD Million (2018-2023)
  • Table 66. Taiwan Healthcare Contract Research Organization, by Type USD Million (2018-2023)
  • Table 67. Taiwan Healthcare Contract Research Organization, by Therapeutic Areas USD Million (2018-2023)
  • Table 68. Taiwan Healthcare Contract Research Organization, by End-User USD Million (2018-2023)
  • Table 69. Taiwan Healthcare Contract Research Organization, by Service Type USD Million (2018-2023)
  • Table 70. Australia Healthcare Contract Research Organization, by Type USD Million (2018-2023)
  • Table 71. Australia Healthcare Contract Research Organization, by Therapeutic Areas USD Million (2018-2023)
  • Table 72. Australia Healthcare Contract Research Organization, by End-User USD Million (2018-2023)
  • Table 73. Australia Healthcare Contract Research Organization, by Service Type USD Million (2018-2023)
  • Table 74. Rest of Asia-Pacific Healthcare Contract Research Organization, by Type USD Million (2018-2023)
  • Table 75. Rest of Asia-Pacific Healthcare Contract Research Organization, by Therapeutic Areas USD Million (2018-2023)
  • Table 76. Rest of Asia-Pacific Healthcare Contract Research Organization, by End-User USD Million (2018-2023)
  • Table 77. Rest of Asia-Pacific Healthcare Contract Research Organization, by Service Type USD Million (2018-2023)
  • Table 78. Europe Healthcare Contract Research Organization, by Country USD Million (2018-2023)
  • Table 79. Europe Healthcare Contract Research Organization, by Type USD Million (2018-2023)
  • Table 80. Europe Healthcare Contract Research Organization, by Therapeutic Areas USD Million (2018-2023)
  • Table 81. Europe Healthcare Contract Research Organization, by End-User USD Million (2018-2023)
  • Table 82. Europe Healthcare Contract Research Organization, by Service Type USD Million (2018-2023)
  • Table 83. Germany Healthcare Contract Research Organization, by Type USD Million (2018-2023)
  • Table 84. Germany Healthcare Contract Research Organization, by Therapeutic Areas USD Million (2018-2023)
  • Table 85. Germany Healthcare Contract Research Organization, by End-User USD Million (2018-2023)
  • Table 86. Germany Healthcare Contract Research Organization, by Service Type USD Million (2018-2023)
  • Table 87. France Healthcare Contract Research Organization, by Type USD Million (2018-2023)
  • Table 88. France Healthcare Contract Research Organization, by Therapeutic Areas USD Million (2018-2023)
  • Table 89. France Healthcare Contract Research Organization, by End-User USD Million (2018-2023)
  • Table 90. France Healthcare Contract Research Organization, by Service Type USD Million (2018-2023)
  • Table 91. Italy Healthcare Contract Research Organization, by Type USD Million (2018-2023)
  • Table 92. Italy Healthcare Contract Research Organization, by Therapeutic Areas USD Million (2018-2023)
  • Table 93. Italy Healthcare Contract Research Organization, by End-User USD Million (2018-2023)
  • Table 94. Italy Healthcare Contract Research Organization, by Service Type USD Million (2018-2023)
  • Table 95. United Kingdom Healthcare Contract Research Organization, by Type USD Million (2018-2023)
  • Table 96. United Kingdom Healthcare Contract Research Organization, by Therapeutic Areas USD Million (2018-2023)
  • Table 97. United Kingdom Healthcare Contract Research Organization, by End-User USD Million (2018-2023)
  • Table 98. United Kingdom Healthcare Contract Research Organization, by Service Type USD Million (2018-2023)
  • Table 99. Netherlands Healthcare Contract Research Organization, by Type USD Million (2018-2023)
  • Table 100. Netherlands Healthcare Contract Research Organization, by Therapeutic Areas USD Million (2018-2023)
  • Table 101. Netherlands Healthcare Contract Research Organization, by End-User USD Million (2018-2023)
  • Table 102. Netherlands Healthcare Contract Research Organization, by Service Type USD Million (2018-2023)
  • Table 103. Rest of Europe Healthcare Contract Research Organization, by Type USD Million (2018-2023)
  • Table 104. Rest of Europe Healthcare Contract Research Organization, by Therapeutic Areas USD Million (2018-2023)
  • Table 105. Rest of Europe Healthcare Contract Research Organization, by End-User USD Million (2018-2023)
  • Table 106. Rest of Europe Healthcare Contract Research Organization, by Service Type USD Million (2018-2023)
  • Table 107. MEA Healthcare Contract Research Organization, by Country USD Million (2018-2023)
  • Table 108. MEA Healthcare Contract Research Organization, by Type USD Million (2018-2023)
  • Table 109. MEA Healthcare Contract Research Organization, by Therapeutic Areas USD Million (2018-2023)
  • Table 110. MEA Healthcare Contract Research Organization, by End-User USD Million (2018-2023)
  • Table 111. MEA Healthcare Contract Research Organization, by Service Type USD Million (2018-2023)
  • Table 112. Middle East Healthcare Contract Research Organization, by Type USD Million (2018-2023)
  • Table 113. Middle East Healthcare Contract Research Organization, by Therapeutic Areas USD Million (2018-2023)
  • Table 114. Middle East Healthcare Contract Research Organization, by End-User USD Million (2018-2023)
  • Table 115. Middle East Healthcare Contract Research Organization, by Service Type USD Million (2018-2023)
  • Table 116. Africa Healthcare Contract Research Organization, by Type USD Million (2018-2023)
  • Table 117. Africa Healthcare Contract Research Organization, by Therapeutic Areas USD Million (2018-2023)
  • Table 118. Africa Healthcare Contract Research Organization, by End-User USD Million (2018-2023)
  • Table 119. Africa Healthcare Contract Research Organization, by Service Type USD Million (2018-2023)
  • Table 120. North America Healthcare Contract Research Organization, by Country USD Million (2018-2023)
  • Table 121. North America Healthcare Contract Research Organization, by Type USD Million (2018-2023)
  • Table 122. North America Healthcare Contract Research Organization, by Therapeutic Areas USD Million (2018-2023)
  • Table 123. North America Healthcare Contract Research Organization, by End-User USD Million (2018-2023)
  • Table 124. North America Healthcare Contract Research Organization, by Service Type USD Million (2018-2023)
  • Table 125. United States Healthcare Contract Research Organization, by Type USD Million (2018-2023)
  • Table 126. United States Healthcare Contract Research Organization, by Therapeutic Areas USD Million (2018-2023)
  • Table 127. United States Healthcare Contract Research Organization, by End-User USD Million (2018-2023)
  • Table 128. United States Healthcare Contract Research Organization, by Service Type USD Million (2018-2023)
  • Table 129. Canada Healthcare Contract Research Organization, by Type USD Million (2018-2023)
  • Table 130. Canada Healthcare Contract Research Organization, by Therapeutic Areas USD Million (2018-2023)
  • Table 131. Canada Healthcare Contract Research Organization, by End-User USD Million (2018-2023)
  • Table 132. Canada Healthcare Contract Research Organization, by Service Type USD Million (2018-2023)
  • Table 133. Mexico Healthcare Contract Research Organization, by Type USD Million (2018-2023)
  • Table 134. Mexico Healthcare Contract Research Organization, by Therapeutic Areas USD Million (2018-2023)
  • Table 135. Mexico Healthcare Contract Research Organization, by End-User USD Million (2018-2023)
  • Table 136. Mexico Healthcare Contract Research Organization, by Service Type USD Million (2018-2023)
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Company Basic Information, Sales Area and Its Competitors
  • Table 144. Company Basic Information, Sales Area and Its Competitors
  • Table 145. Company Basic Information, Sales Area and Its Competitors
  • Table 146. Company Basic Information, Sales Area and Its Competitors
  • Table 147. Healthcare Contract Research Organization: by Type(USD Million)
  • Table 148. Healthcare Contract Research Organization Early Phase development , by Region USD Million (2025-2030)
  • Table 149. Healthcare Contract Research Organization Clinical research , by Region USD Million (2025-2030)
  • Table 150. Healthcare Contract Research Organization Laboratory regulatory Consulting , by Region USD Million (2025-2030)
  • Table 151. Healthcare Contract Research Organization: by Therapeutic Areas(USD Million)
  • Table 152. Healthcare Contract Research Organization Oncology , by Region USD Million (2025-2030)
  • Table 153. Healthcare Contract Research Organization CNS Disorder , by Region USD Million (2025-2030)
  • Table 154. Healthcare Contract Research Organization Cardiovascular Disease , by Region USD Million (2025-2030)
  • Table 155. Healthcare Contract Research Organization Metabolic Disease , by Region USD Million (2025-2030)
  • Table 156. Healthcare Contract Research Organization Infectious Disease , by Region USD Million (2025-2030)
  • Table 157. Healthcare Contract Research Organization Immunological Disorders , by Region USD Million (2025-2030)
  • Table 158. Healthcare Contract Research Organization Respiratory Disorders , by Region USD Million (2025-2030)
  • Table 159. Healthcare Contract Research Organization Diabetes , by Region USD Million (2025-2030)
  • Table 160. Healthcare Contract Research Organization Other , by Region USD Million (2025-2030)
  • Table 161. Healthcare Contract Research Organization: by End-User(USD Million)
  • Table 162. Healthcare Contract Research Organization Pharmaceutical and Biopharmaceutical Companies , by Region USD Million (2025-2030)
  • Table 163. Healthcare Contract Research Organization Medical Device Companies , by Region USD Million (2025-2030)
  • Table 164. Healthcare Contract Research Organization Academic Institutes , by Region USD Million (2025-2030)
  • Table 165. Healthcare Contract Research Organization: by Service Type(USD Million)
  • Table 166. Healthcare Contract Research Organization Early Phase Development Services {Discovery Studies, Chemistry, Manufacturing & Control, Preclinical Services} , by Region USD Million (2025-2030)
  • Table 167. Healthcare Contract Research Organization Pharmacokinetics /Pharmacodynamics , by Region USD Million (2025-2030)
  • Table 168. Healthcare Contract Research Organization Toxicology Testing , by Region USD Million (2025-2030)
  • Table 169. Healthcare Contract Research Organization Clinic Research Services {Phase I, Phase II, Phase III, Phase IV} , by Region USD Million (2025-2030)
  • Table 170. Healthcare Contract Research Organization Laboratory Services {Bioanalytical Testing, Analytical Testing} , by Region USD Million (2025-2030)
  • Table 171. Healthcare Contract Research Organization Physical Characterization , by Region USD Million (2025-2030)
  • Table 172. Healthcare Contract Research Organization Testing {Stability Testing, Batch Release Testing, Raw Material Testing, Other Analytical Testing} , by Region USD Million (2025-2030)
  • Table 173. Healthcare Contract Research Organization Consulting Services , by Region USD Million (2025-2030)
  • Table 174. South America Healthcare Contract Research Organization, by Country USD Million (2025-2030)
  • Table 175. South America Healthcare Contract Research Organization, by Type USD Million (2025-2030)
  • Table 176. South America Healthcare Contract Research Organization, by Therapeutic Areas USD Million (2025-2030)
  • Table 177. South America Healthcare Contract Research Organization, by End-User USD Million (2025-2030)
  • Table 178. South America Healthcare Contract Research Organization, by Service Type USD Million (2025-2030)
  • Table 179. Brazil Healthcare Contract Research Organization, by Type USD Million (2025-2030)
  • Table 180. Brazil Healthcare Contract Research Organization, by Therapeutic Areas USD Million (2025-2030)
  • Table 181. Brazil Healthcare Contract Research Organization, by End-User USD Million (2025-2030)
  • Table 182. Brazil Healthcare Contract Research Organization, by Service Type USD Million (2025-2030)
  • Table 183. Argentina Healthcare Contract Research Organization, by Type USD Million (2025-2030)
  • Table 184. Argentina Healthcare Contract Research Organization, by Therapeutic Areas USD Million (2025-2030)
  • Table 185. Argentina Healthcare Contract Research Organization, by End-User USD Million (2025-2030)
  • Table 186. Argentina Healthcare Contract Research Organization, by Service Type USD Million (2025-2030)
  • Table 187. Rest of South America Healthcare Contract Research Organization, by Type USD Million (2025-2030)
  • Table 188. Rest of South America Healthcare Contract Research Organization, by Therapeutic Areas USD Million (2025-2030)
  • Table 189. Rest of South America Healthcare Contract Research Organization, by End-User USD Million (2025-2030)
  • Table 190. Rest of South America Healthcare Contract Research Organization, by Service Type USD Million (2025-2030)
  • Table 191. Asia Pacific Healthcare Contract Research Organization, by Country USD Million (2025-2030)
  • Table 192. Asia Pacific Healthcare Contract Research Organization, by Type USD Million (2025-2030)
  • Table 193. Asia Pacific Healthcare Contract Research Organization, by Therapeutic Areas USD Million (2025-2030)
  • Table 194. Asia Pacific Healthcare Contract Research Organization, by End-User USD Million (2025-2030)
  • Table 195. Asia Pacific Healthcare Contract Research Organization, by Service Type USD Million (2025-2030)
  • Table 196. China Healthcare Contract Research Organization, by Type USD Million (2025-2030)
  • Table 197. China Healthcare Contract Research Organization, by Therapeutic Areas USD Million (2025-2030)
  • Table 198. China Healthcare Contract Research Organization, by End-User USD Million (2025-2030)
  • Table 199. China Healthcare Contract Research Organization, by Service Type USD Million (2025-2030)
  • Table 200. Japan Healthcare Contract Research Organization, by Type USD Million (2025-2030)
  • Table 201. Japan Healthcare Contract Research Organization, by Therapeutic Areas USD Million (2025-2030)
  • Table 202. Japan Healthcare Contract Research Organization, by End-User USD Million (2025-2030)
  • Table 203. Japan Healthcare Contract Research Organization, by Service Type USD Million (2025-2030)
  • Table 204. India Healthcare Contract Research Organization, by Type USD Million (2025-2030)
  • Table 205. India Healthcare Contract Research Organization, by Therapeutic Areas USD Million (2025-2030)
  • Table 206. India Healthcare Contract Research Organization, by End-User USD Million (2025-2030)
  • Table 207. India Healthcare Contract Research Organization, by Service Type USD Million (2025-2030)
  • Table 208. South Korea Healthcare Contract Research Organization, by Type USD Million (2025-2030)
  • Table 209. South Korea Healthcare Contract Research Organization, by Therapeutic Areas USD Million (2025-2030)
  • Table 210. South Korea Healthcare Contract Research Organization, by End-User USD Million (2025-2030)
  • Table 211. South Korea Healthcare Contract Research Organization, by Service Type USD Million (2025-2030)
  • Table 212. Taiwan Healthcare Contract Research Organization, by Type USD Million (2025-2030)
  • Table 213. Taiwan Healthcare Contract Research Organization, by Therapeutic Areas USD Million (2025-2030)
  • Table 214. Taiwan Healthcare Contract Research Organization, by End-User USD Million (2025-2030)
  • Table 215. Taiwan Healthcare Contract Research Organization, by Service Type USD Million (2025-2030)
  • Table 216. Australia Healthcare Contract Research Organization, by Type USD Million (2025-2030)
  • Table 217. Australia Healthcare Contract Research Organization, by Therapeutic Areas USD Million (2025-2030)
  • Table 218. Australia Healthcare Contract Research Organization, by End-User USD Million (2025-2030)
  • Table 219. Australia Healthcare Contract Research Organization, by Service Type USD Million (2025-2030)
  • Table 220. Rest of Asia-Pacific Healthcare Contract Research Organization, by Type USD Million (2025-2030)
  • Table 221. Rest of Asia-Pacific Healthcare Contract Research Organization, by Therapeutic Areas USD Million (2025-2030)
  • Table 222. Rest of Asia-Pacific Healthcare Contract Research Organization, by End-User USD Million (2025-2030)
  • Table 223. Rest of Asia-Pacific Healthcare Contract Research Organization, by Service Type USD Million (2025-2030)
  • Table 224. Europe Healthcare Contract Research Organization, by Country USD Million (2025-2030)
  • Table 225. Europe Healthcare Contract Research Organization, by Type USD Million (2025-2030)
  • Table 226. Europe Healthcare Contract Research Organization, by Therapeutic Areas USD Million (2025-2030)
  • Table 227. Europe Healthcare Contract Research Organization, by End-User USD Million (2025-2030)
  • Table 228. Europe Healthcare Contract Research Organization, by Service Type USD Million (2025-2030)
  • Table 229. Germany Healthcare Contract Research Organization, by Type USD Million (2025-2030)
  • Table 230. Germany Healthcare Contract Research Organization, by Therapeutic Areas USD Million (2025-2030)
  • Table 231. Germany Healthcare Contract Research Organization, by End-User USD Million (2025-2030)
  • Table 232. Germany Healthcare Contract Research Organization, by Service Type USD Million (2025-2030)
  • Table 233. France Healthcare Contract Research Organization, by Type USD Million (2025-2030)
  • Table 234. France Healthcare Contract Research Organization, by Therapeutic Areas USD Million (2025-2030)
  • Table 235. France Healthcare Contract Research Organization, by End-User USD Million (2025-2030)
  • Table 236. France Healthcare Contract Research Organization, by Service Type USD Million (2025-2030)
  • Table 237. Italy Healthcare Contract Research Organization, by Type USD Million (2025-2030)
  • Table 238. Italy Healthcare Contract Research Organization, by Therapeutic Areas USD Million (2025-2030)
  • Table 239. Italy Healthcare Contract Research Organization, by End-User USD Million (2025-2030)
  • Table 240. Italy Healthcare Contract Research Organization, by Service Type USD Million (2025-2030)
  • Table 241. United Kingdom Healthcare Contract Research Organization, by Type USD Million (2025-2030)
  • Table 242. United Kingdom Healthcare Contract Research Organization, by Therapeutic Areas USD Million (2025-2030)
  • Table 243. United Kingdom Healthcare Contract Research Organization, by End-User USD Million (2025-2030)
  • Table 244. United Kingdom Healthcare Contract Research Organization, by Service Type USD Million (2025-2030)
  • Table 245. Netherlands Healthcare Contract Research Organization, by Type USD Million (2025-2030)
  • Table 246. Netherlands Healthcare Contract Research Organization, by Therapeutic Areas USD Million (2025-2030)
  • Table 247. Netherlands Healthcare Contract Research Organization, by End-User USD Million (2025-2030)
  • Table 248. Netherlands Healthcare Contract Research Organization, by Service Type USD Million (2025-2030)
  • Table 249. Rest of Europe Healthcare Contract Research Organization, by Type USD Million (2025-2030)
  • Table 250. Rest of Europe Healthcare Contract Research Organization, by Therapeutic Areas USD Million (2025-2030)
  • Table 251. Rest of Europe Healthcare Contract Research Organization, by End-User USD Million (2025-2030)
  • Table 252. Rest of Europe Healthcare Contract Research Organization, by Service Type USD Million (2025-2030)
  • Table 253. MEA Healthcare Contract Research Organization, by Country USD Million (2025-2030)
  • Table 254. MEA Healthcare Contract Research Organization, by Type USD Million (2025-2030)
  • Table 255. MEA Healthcare Contract Research Organization, by Therapeutic Areas USD Million (2025-2030)
  • Table 256. MEA Healthcare Contract Research Organization, by End-User USD Million (2025-2030)
  • Table 257. MEA Healthcare Contract Research Organization, by Service Type USD Million (2025-2030)
  • Table 258. Middle East Healthcare Contract Research Organization, by Type USD Million (2025-2030)
  • Table 259. Middle East Healthcare Contract Research Organization, by Therapeutic Areas USD Million (2025-2030)
  • Table 260. Middle East Healthcare Contract Research Organization, by End-User USD Million (2025-2030)
  • Table 261. Middle East Healthcare Contract Research Organization, by Service Type USD Million (2025-2030)
  • Table 262. Africa Healthcare Contract Research Organization, by Type USD Million (2025-2030)
  • Table 263. Africa Healthcare Contract Research Organization, by Therapeutic Areas USD Million (2025-2030)
  • Table 264. Africa Healthcare Contract Research Organization, by End-User USD Million (2025-2030)
  • Table 265. Africa Healthcare Contract Research Organization, by Service Type USD Million (2025-2030)
  • Table 266. North America Healthcare Contract Research Organization, by Country USD Million (2025-2030)
  • Table 267. North America Healthcare Contract Research Organization, by Type USD Million (2025-2030)
  • Table 268. North America Healthcare Contract Research Organization, by Therapeutic Areas USD Million (2025-2030)
  • Table 269. North America Healthcare Contract Research Organization, by End-User USD Million (2025-2030)
  • Table 270. North America Healthcare Contract Research Organization, by Service Type USD Million (2025-2030)
  • Table 271. United States Healthcare Contract Research Organization, by Type USD Million (2025-2030)
  • Table 272. United States Healthcare Contract Research Organization, by Therapeutic Areas USD Million (2025-2030)
  • Table 273. United States Healthcare Contract Research Organization, by End-User USD Million (2025-2030)
  • Table 274. United States Healthcare Contract Research Organization, by Service Type USD Million (2025-2030)
  • Table 275. Canada Healthcare Contract Research Organization, by Type USD Million (2025-2030)
  • Table 276. Canada Healthcare Contract Research Organization, by Therapeutic Areas USD Million (2025-2030)
  • Table 277. Canada Healthcare Contract Research Organization, by End-User USD Million (2025-2030)
  • Table 278. Canada Healthcare Contract Research Organization, by Service Type USD Million (2025-2030)
  • Table 279. Mexico Healthcare Contract Research Organization, by Type USD Million (2025-2030)
  • Table 280. Mexico Healthcare Contract Research Organization, by Therapeutic Areas USD Million (2025-2030)
  • Table 281. Mexico Healthcare Contract Research Organization, by End-User USD Million (2025-2030)
  • Table 282. Mexico Healthcare Contract Research Organization, by Service Type USD Million (2025-2030)
  • Table 283. Research Programs/Design for This Report
  • Table 284. Key Data Information from Secondary Sources
  • Table 285. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Healthcare Contract Research Organization: by Type USD Million (2018-2023)
  • Figure 5. Global Healthcare Contract Research Organization: by Therapeutic Areas USD Million (2018-2023)
  • Figure 6. Global Healthcare Contract Research Organization: by End-User USD Million (2018-2023)
  • Figure 7. Global Healthcare Contract Research Organization: by Service Type USD Million (2018-2023)
  • Figure 8. South America Healthcare Contract Research Organization Share (%), by Country
  • Figure 9. Asia Pacific Healthcare Contract Research Organization Share (%), by Country
  • Figure 10. Europe Healthcare Contract Research Organization Share (%), by Country
  • Figure 11. MEA Healthcare Contract Research Organization Share (%), by Country
  • Figure 12. North America Healthcare Contract Research Organization Share (%), by Country
  • Figure 13. Global Healthcare Contract Research Organization share by Players 2023 (%)
  • Figure 14. Global Healthcare Contract Research Organization share by Players (Top 3) 2023(%)
  • Figure 15. Global Healthcare Contract Research Organization share by Players (Top 5) 2023(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. IQVIA Holdings, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 18. IQVIA Holdings, Inc. (United States) Revenue: by Geography 2023
  • Figure 19. Laboratory Corporation of America Holdings (United States) Revenue, Net Income and Gross profit
  • Figure 20. Laboratory Corporation of America Holdings (United States) Revenue: by Geography 2023
  • Figure 21. Pharmaceutical Product Development, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 22. Pharmaceutical Product Development, Inc. (United States) Revenue: by Geography 2023
  • Figure 23. Parexel International Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 24. Parexel International Corporation (United States) Revenue: by Geography 2023
  • Figure 25. Charles River Laboratories International, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Charles River Laboratories International, Inc. (United States) Revenue: by Geography 2023
  • Figure 27. ICON PLC (Ireland) Revenue, Net Income and Gross profit
  • Figure 28. ICON PLC (Ireland) Revenue: by Geography 2023
  • Figure 29. Medidata Solutions, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. Medidata Solutions, Inc. (United States) Revenue: by Geography 2023
  • Figure 31. Syneos Health, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. Syneos Health, Inc. (United States) Revenue: by Geography 2023
  • Figure 33. Pharmaron Beijing Co., Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 34. Pharmaron Beijing Co., Ltd. (China) Revenue: by Geography 2023
  • Figure 35. GVK Biosciences Private Limited (India) Revenue, Net Income and Gross profit
  • Figure 36. GVK Biosciences Private Limited (India) Revenue: by Geography 2023
  • Figure 37. Global Healthcare Contract Research Organization: by Type USD Million (2025-2030)
  • Figure 38. Global Healthcare Contract Research Organization: by Therapeutic Areas USD Million (2025-2030)
  • Figure 39. Global Healthcare Contract Research Organization: by End-User USD Million (2025-2030)
  • Figure 40. Global Healthcare Contract Research Organization: by Service Type USD Million (2025-2030)
  • Figure 41. South America Healthcare Contract Research Organization Share (%), by Country
  • Figure 42. Asia Pacific Healthcare Contract Research Organization Share (%), by Country
  • Figure 43. Europe Healthcare Contract Research Organization Share (%), by Country
  • Figure 44. MEA Healthcare Contract Research Organization Share (%), by Country
  • Figure 45. North America Healthcare Contract Research Organization Share (%), by Country
List of companies from research coverage that are profiled in the study
  • IQVIA Holdings, Inc. (United States)
  • Laboratory Corporation of America Holdings (United States)
  • Pharmaceutical Product Development, Inc. (United States)
  • Parexel International Corporation (United States)
  • Charles River Laboratories International, Inc. (United States)
  • ICON PLC (Ireland)
  • Medidata Solutions, Inc. (United States)
  • Syneos Health, Inc. (United States)
  • Pharmaron Beijing Co., Ltd. (China)
  • GVK Biosciences Private Limited (India)
Additional players considered in the study are as follows:
SGS SA (Switzerland) , EPS International Co., Ltd (Japan) , Genscript Biotech (United States)
Select User Access Type

Key Highlights of Report


Mar 2024 246 Pages 59 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Healthcare Contract Research Organization Market Quantitative research analysis
Global Healthcare Contract Research Organization Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as IQVIA Holdings, Inc. (United States), Laboratory Corporation of America Holdings (United States), Pharmaceutical Product Development, Inc. (United States), Parexel International Corporation (United States), Charles River Laboratories International, Inc. (United States), ICON PLC (Ireland), Medidata Solutions, Inc. (United States), Syneos Health, Inc. (United States), Pharmaron Beijing Co., Ltd. (China) and GVK Biosciences Private Limited (India) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Growing Consolidation in the CROs Industry" is seen as one of major influencing trends for Healthcare Contract Research Organization Market during projected period 2023-2030.
The Healthcare Contract Research Organization market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Healthcare Contract Research Organization Market Report?

Have a Query? Click Here

Other Related Reports

Human Papillomavirus Testing Comprehensive Study by Type (Primary Testing, Follow-up Testing, Co-Testing), Application (Immunoassays, Monoclonal and Polyclonal Antibodies, Microarrays, Molecular Diag...
$ 3650
Paramedic Services Comprehensive Study by Type (Emergency Paramedic Services, General Paramedic Services), Application (Pre-hospital Support, Post-hospital Support), Service Level (Basic Life Support...
$ 3750
Bovine Mastitis  Comprehensive Study by Therapy (Lactating Period, Dry Period {Antibiotics, Others}), Mastitis (Clinical mastitis, Sub-Clinical mastitis, Peracute mastitis, Acute mastitis, Subacute ...
$ 3750
Histopathology Services Comprehensive Study by Examination (Surgical Specimen, Breast Biopsy, Gastrointestinal Biopsy, Testicular Biopsy, Lung Biopsy, Renal Biopsy, Biopsy of Gynecological Cancers, L...
$ 3750
Vaccine Storage & Packaging Comprehensive Study by Type (Vaccine Storage, Vaccine Packaging), Vaccine Packaging (Packaging (Vaccine Cool Bags, Vials, and Ampoules, Corrugated Boxes, Others), Packagin...
$ 3750
Animal Treatment Comprehensive Study by Type (Pharmaceuticals, Feed Additives), Application (Laboratory Services, Animal Emergency Care, Pain Management, Animal Specialty Services, Vitamins and Suppl...
$ 3650